Bicara Therapeutics Market Sentiment

SPY767.34+0.54%QQQ719.44+1.36%BTC/USD—DIA519.20+0.02%GLD379.30−0.71%TLT79.46−0.74%

Premium

Bicara Therapeutics Inc

BCAXNASDAQ

Trade with Public

$17.00

0.221.31%

Last update: Oct 19, 7:20 AM

$17.00

0.221.31%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Bicara Therapeutics Market Sentiment - Benzinga

Bicara Therapeutics Market Sentiment

Market sentiment signals for Bicara Therapeutics (BCAX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 22.5% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

15 analysts

Options Flow (P/C)

0.00

More calls — Bullish

220 calls · 0 puts

Avg Consensus PT

$33

+91.2%

Highest Price Target

$47

+176.5%

Stifel

Lowest Price Target

$13

-23.5%

Cantor Fitzgerald

Short Interest

22.5%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 19, 2026	BTIG	Jeet Mukherjee —	+129.4%	$39 → $39	Maintained	Buy
Aug 19, 2026	BMO Capital	David Lebowitz—	+105.9%	$35	Initiate	Outperform
Aug 12, 2026	Goldman Sachs	Richard Law—	+17.6%	$18 → $20	Maintained	Neutral
Aug 12, 2026	Wedbush	David Nierengarten—	+94.1%	$30 → $33	Maintained	Outperform
Aug 12, 2026	Morgan Stanley	Judah Frommer—	+129.4%	$37 → $39	Maintained	Overweight
Aug 12, 2026	Mizuho	Joseph Catanzaro—	+17.6%	$18 → $20	Maintained	Neutral
Aug 12, 2026	Wells Fargo	Eva Fortea Verdejo—	+35.3%	$16 → $23	Maintained	Equal-Weight
Aug 12, 2026	BTIG	Jeet Mukherjee —	+129.4%	$28 → $39	Maintained	Buy
May 12, 2026	Goldman Sachs	Richard Law—	+5.9%	$16 → $18	Maintained	Neutral
May 12, 2026	Morgan Stanley	Judah Frommer—	+117.6%	$36 → $37	Maintained	Overweight
May 11, 2026	Guggenheim	Brad Canino—	+147.1%	$42	Initiate	Buy
Mar 31, 2026	Goldman Sachs	Richard Law—	-5.9%	$14 → $16	Maintained	Neutral
Mar 31, 2026	Wedbush	David Nierengarten—	+76.5%	$30 → $30	Maintained	Outperform
Mar 31, 2026	Wells Fargo	Eva Fortea Verdejo—	-5.9%	$11 → $16	Maintained	Equal-Weight
Mar 31, 2026	Citizens	Reni J. Benjamin—	+82.4%	$31 → $31	Maintained	Market Outperform
Mar 31, 2026	HC Wainwright & Co.	Robert Burns—	+147.1%	$40 → $42	Maintained	Buy
Mar 25, 2026	B of A Securities	Tazeen Ahmad—	+105.9%	$35	Initiate	Buy
Jan 29, 2026	Citizens	Reni J. Benjamin—	+82.4%	$31	Initiate	Market Outperform
Jan 13, 2026	Wedbush	David Nierengarten—	+76.5%	$30 → $30	Maintained	Outperform
Jan 8, 2026	BTIG	Jeet Mukherjee —	+64.7%	$28	Initiate	Buy
Dec 18, 2025	Mizuho	Joseph Catanzaro—	+5.9%	$18	Initiate	Neutral
Nov 11, 2025	Wells Fargo	Eva Fortea Verdejo—	-35.3%	$8 → $11	Maintained	Equal-Weight
Aug 22, 2025	HC Wainwright & Co.	Robert Burns—	+135.3%	$41 → $40	Maintained	Buy
Aug 19, 2025	Piper Sandler	Kelsey Goodwin—	+111.8%	$36	Initiate	Overweight
May 23, 2025	Wells Fargo	Eva Fortea Verdejo—	-52.9%	$8 → $8	Upgrade	Underweight→Equal-Weight

More with Benzinga EdgeGet Access

Bicara Therapeutics Inc

Bicara Therapeutics Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

Bulls vs Bears

People Also Watch